Paritaprevir/r - Ombitasvir, ± Dasabuvir, ± Ribavirin in Patients With Chronic Hepatitis C - An Observational Study in Austria (REAL)

NCT02582658 · clinicaltrials.gov ↗
COMPLETED
Status
173
Enrollment
INDUSTRY
Sponsor class

Conditions

Sponsor

AbbVie